HROW News and Press, Harrow Health Inc. From 06/18/24

2024-06-18 23:39:00 ET Summary Investing in individual high yield bonds can outperform high yield bond funds by examining reward to risk. Analyzing current high yield bonds can help identify bonds with the highest reward to risk for superior returns. A list of high yield bonds...

Topline Readout Expected in Q4 2024 Melt Pharmaceuticals, Inc. (“Melt”), a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced that the first patient has been dosed in its Phase 3 program evaluating the safety and effi...

2024-06-05 13:00:00 ET Summary The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Albertsons, Viking Therapeutics, Brandywine Realty Trust, platinum, and more are discussed in this edition. A number of veteran Seeking Alph...

Data Demonstrates Sustained Safety and Efficacy in Treating Signs and Symptoms of Dry Eye Disease Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, is pleased to announce results from its ESSENCE‑2 open-label extension (OLE) clinical study for VEVYE&...

2024-06-03 10:15:02 ET Lake Street analyst issues BUY recommendation for HROW on June 3, 2024 08:56AM ET. The previous analyst recommendation was Buy. HROW was trading at $18.125 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...

2024-06-03 10:00:06 ET Brooks O'Neil from Lake Street issued a price target of $25.00 for HROW on 2024-06-03 08:56:00. The adjusted price target was set to $25.00. At the time of the announcement, HROW was trading at $18.125. HROW currently trades -19.22% versus its 52 w...

2024-05-24 12:12:17 ET Summary Bausch + Lomb (BLCO) is a company with entrenched brands but poor recent financial performance. The company issued debt to acquire Dry Eye Disease [DED] drug Xiidra, hoping to ramp revenue to a more sensible level given their high fixed costs. Th...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor conferences in May: B. Riley Securities 24 th Annual Institutional Investor Conference (Beverly Hilton Hotel, Beverly Hills, C...

2024-05-14 13:44:42 ET More on mid-day movers & stocks. JanOne to acquire blockchain financial technology provider ALT 5 Sigma Financial information for JanOne Financial information for Mmtec Seeking Alpha’s Quant Rating on ProKidney Histor...

Harrow Health, Inc. (NASDAQ: HROW) is one of today's top gainers. The company's shares have moved 33.64% on the day to $16.11. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding busi...